Abstract: An aerosol generating article for use in an aerosol generating assembly, the aerosol generating article including an aerosol generating substrate having an aerosol generating material, wherein the aerosol generating material is solid and includes a starch and a plasticizer, wherein the amount of plasticizer is from about 5% to 70% by weight of the starch.

Abstract: In an apparatus for the doping of vessel supports (stents) with radioactive and non-radioactive atoms comprising an electron-cyclotron-ion-source (ECRIS) with an arrangement for extracting an ion beam from the ECRIS, a magnetic separation device for the splitting of the ion beam arranged in a downstream area of the extracted ion beam and an irradiation chamber in which the vessel supports are exposed to the selected partial ion beam, the ECRIS includes a microwave-permeable plasma chamber with a magnetic, six-pole arrangement, an electrically conductive tube portion disposed within the plasma chamber co-axially with the six-pole arrangement and having an in-coupling opening and also being axially movable for an adjustment of an optimal in-coupling and a co-axial cable extends through the in-coupling opening and has an outer sleeve which is in electrical contact and an inner conductor which is electrically insulated and forms at the inner wall of the tube a flat loop whose end is in contact with the tube wall.

Abstract: Novel 6-(acylaminaryl)-3(2H)-pyridazinones of the formula ##STR1## where R.sup.1, R.sup.2, R.sup.3, R.sup.4, A and B have the meanings given in the description, and their preparation are described.The compounds have thrombocyte aggregation-inhibiting activity.

Abstract: Novel 6-(acylaminoaryl)-3(2H)-pyridazinones of the formula ##STR1## where R.sup.1, R.sup.2, R.sup.3, R.sup.4, A and B have the meanings given in the description, and their preparation are described and inhibiting thrombocyte aggregation and gastric secretion.The compounds are useful for treating disorders.

Abstract: Thiazolyloxamic acids and their derivatives of the general formula I ##STR1## processes for their preparation, and pharmaceutical formulations which contain these compounds and are useful as drugs for treating allergic disorders.

Abstract: N-substituted imidazole derivatives of the formula I ##STR1## where R.sup.1, R.sup.2 and R.sup.3 are identical or different and are each hydrogen or alkyl with 1 or 3 carbon atoms and Alk is an alkylene chain of 2 to 4 carbon atoms, and their salts with physiologically tolerated acids, processes for their preparation, drugs containing a compound of the formula I or one of its salts, and their use for treating disorders associated with gastric hyperacidity.

Abstract: 5,6-Dihydro-11-methylenemorphanthridin-6-ones of the formula I ##STR1## where R.sup.1, R.sup.2, R.sup.3 and R.sup.4 have the meanings given in the description, and their preparation and use.The novel substances are particularly useful for treating gastric and duodenal ulcers.

Abstract: 1,2,4-Triazolo[1,5-c]-quinazolinones of the general formula I ##STR1## and their pharmaceutically tolerated salts, processes for their preparation and pharmaceutical formulations which contain these compounds and are useful drugs in the treatment of allergic disorders.

Abstract: Disclosed is a control system for an ink blade of a printing machine provided with a series of key setting units each having a key position sensor and a key drive controlled by an adjusting device described in patent application Ser. No. 252,126. In order to achieve proper adjustment of marginal key setting units, there is provided a switching unit with a plurality of contacts assigned to respective key position measuring sensors and including additional switching contacts assigned to imaginary key position setting units adjoining the real setting units at each end of the ink zone. The additional marginal switching contacts are connected to the output of assigned sample-and-hold members which apply thereto the measured value from the extreme actual position sensors so that comparing differential transducer comparing the measured values of consecutive pairs of position sensors always produces a starting difference which does not exceed a predetermined limit value.

Abstract: .omega.-Cyano-1,.omega.-diphenyl-azaalkane derivatives of the formula I ##STR1## where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, m and n have the meanings given in the description, and salts thereof with physiologically tolerated acids, are useful in treating cardiovascular disorders.

Abstract: Novel 2-substituted thiazol-2-yl-oxamic acid esters, processes for their preparation, and therapeutic agents which contain these compounds and are useful in the treatment of allergic disorders.

Abstract: Novel 5,6-dihydro-11-alkylene-morphanthridin-6-ones of the formula ##STR1## where R.sup.1, R.sup.2, R.sup.3 and R.sup.4 have the meanings given in the description, their preparation and their use.The novel compounds are particularly useful in the treatment of gastric and duodenal ulcers.

Abstract: A control device for remote adjustments of ink zones in a printing press includes a control system comprising program request control connected respectively to multiplexers provided at the input side of the control system and to multiplexers provided at the output side of the control system, and a single motor control system. The multiplexers are connected to an adjustment system activating ink knife support elements. The control device further includes a differential former interconnected between the program control request and the multiplexers at the input side of the control system, and a computer interconnected between the differential former and the single motor control unit. The motor control unit controls the adjustment system so that the unsteady course of the positions of the ink knife support elements is balanced to the steady function of the knife bending curve.

Abstract: Bispidine derivatives of the formula ##STR1## where R.sup.1 is H or C.sub.6 H.sub.5, R.sup.2 is H, Cl or CF.sub.3, R.sup.3 is H, F or Cl and X is 0 or 1, and drugs which contain these compounds. The compounds are prepared by condensing N-monobenzylbispidine with appropriately substituted phenylethyl halides or by a Mannich reaction of N-benzylpiperid-4-one with appropriately substituted phenylalkylamines, followed by reduction. They exhibit mainly anti-arrhythmic action.

Abstract: Hypolipemic non-glycosidic theophylline-sugar compounds having the formula ##STR1## are disclosed, as are a method for making them and methods and compositions for treating hyperlipemia with the compounds.

Abstract: An automatic flash-limiting arrangement for use in combination with a flash unit associated with a camera and arranged to automatically terminate the light flash produced by the unit when the subject has been properly exposed, the flash-limiting arrangement being associated with the flash unit so as to become operative only upon initiation of a light flash, thus assuring that the arrangement will not respond to extraneous flashes occurring before the flash which is to be controlled. The flash-limiting arrangement is constructed to sense the light being received by the camera, to produce a signal which is the sum of a component proportional to the time integral of the intensity of such light and a component which is proportional to the instantaneous amplitude of the intensity of such light, and to terminate the flash when this signal reaches a predetermined value.

Abstract: Isoquinoline compounds having .beta.-receptor blocking activity, particularly for the heart, and having the formula ##STR1## and salts thereof with physiologically tolerable acids, wherein R.sub.1 is hydrogen or methyl, R.sub.2 is hydrogen or lower alkyl, R.sub.3 is hydrogen or methoxy, and R.sub.4 is isopropyl or tertiary butyl. A method for making such compounds. Pharmaceutical compositions containing such compounds.

Abstract: Novel 6-(acylaminoaryl)-3(2H)-pyridazinones of the formula ##STR1## where R.sup.1, R.sup.2, R.sup.3, R.sup.4, A and B have the meanings given in the description, and their preparation are described.[.and inhibiting thrombocyte aggregation and gastric secretion.]..The compounds are useful for treating disorders .Iadd.and inhibiting thrombocyte aggregation and gastric secretion.Iaddend..